MSH|^~\&|LAB|ARH|||201910281036||ORU^R01|4091072|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|145^^Y|mmol/L|135-145|N||A^S|F|||201910281020
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|3.4^^Y|mmol/L|3.5-5.0|L||A^S|F|||201910281020
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|105^^Y|mmol/L|98-108|N||A^S|F|||201910281020
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|25^^Y|mmol/L|20-30|N||A^S|F|||201910281020
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|15^^Y|mmol/L|3-16|N||A^S|F|||201910281020
OBX|6|ST|500.2400^UREA^Urea^^14937-7^22664-7|1|8^^Y|mmol/L|2-9|N||A^S|F|||201910281020
OBX|7|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|70^^Y|umol/L|45-90|N||A^S|F|||201910281020
OBX|8|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|88^^Y|mL/min|>60|N||A^S|F|||201910281020
OBX|9|ST|500.2900^GLU^Glucose, Random^^14749-6^14749-6|1|2.0^^Y|mmol/L|3.6-7.8|LL||A^S|F|||201910281020
NTE|1||*CRITICAL VALUE
OBR|2|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3800^CA^Calcium^^2000-8^2000-8||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.3800^CA^Calcium^^2000-8^2000-8|1|1.00^^Y|mmol/L|2.10-2.60|LL||A^S|F|||201910281020
NTE|1||*CRITICAL VALUE
OBR|3|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.3900^MG^Magnesium^^2601-3^2601-3||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.3900^MG^Magnesium^^2601-3^2601-3|1|1.1^^Y|mmol/L|0.7-1.2|N||A^S|F|||201910281020
OBR|4|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4000^PHOS^Phosphate^^14879-1^14879-1||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.4000^PHOS^Phosphate^^14879-1^14879-1|1|1.0^^Y|mmol/L|0.8-1.5|N||A^S|F|||201910281020
OBR|5|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.4200^LFT^TP,ALB,GGT,AST,ALT,BILT,ALK^^^XXX-1710||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.4500^PROT^Protein^^2885-2^2885-2|1|90^^Y|g/L|55-80|H||A^S|F|||201910281020
OBX|2|ST|500.4600^ALB^Albumin^^1751-7^61152-5|1|70^^Y|g/L|35-50|H||A^S|F|||201910281020
OBX|3|ST|500.4700^ALK^Alkaline Phosphatase^^6768-6^6768-6|1|200^^Y|U/L|35-105|H||A^S|F|||201910281020
OBX|4|ST|500.4800^GGT^Gamma Glutamyl Transferase^^2324-2^2324-2|1|400^^Y|U/L|<31|H||A^S|F|||201910281020
OBX|5|ST|500.4900^ALT^Alanine Aminotransferase^^1742-6^1744-2|1|70^^Y|U/L|<36|H||A^S|F|||201910281020
OBX|6|ST|500.5000^AST^Aspartate Aminotransferase^^1920-8^1920-8|1|35^^Y|U/L|<36|N||A^S|F|||201910281020
OBX|7|ST|500.5200^BILT^Bilirubin, Total^^14631-6^14631-6|1|50^^Y|umol/L|2-17|H||A^S|F|||201910281020
OBR|6|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5690^TROP^Troponin I^^^10839-9||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.5695^TROPIHS^Troponin I High Sensitivity^^89579-7^89579-7|1|5^^Y|ng/L|<18|N||A^S|F|||201910281020
NTE|1||Detectable Troponin I present. To assess the risk of acute
NTE|2||myocardial injury, consider repeat Troponin I in 3 hours to
NTE|3||evaluate the change ("delta"). If this is a follow up
NTE|4||Troponin I collected within 3-6 hours of previous:
NTE|5||Delta < 11 ng/L: Acute myocardial injury is unlikely.
NTE|6||Delta 11 - 21 ng/L: Consistent with myocardial injury, but
NTE|7||low positive predictive value for an acute event. Consider a
NTE|8||further Troponin I in another 3 hours to re-evaluate.
NTE|9||Delta >= 22 ng/L: Critical change in Troponin I. Result is
NTE|10||highly predictive for acute myocardial injury.
OBR|7|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.5800^CK^Creatine Kinase^^2157-6^2157-6||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.5800^CK^Creatine Kinase^^2157-6^2157-6|1|100^^Y|U/L|<140|N||A^S|F|||201910281020
OBR|8|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|6.0^^Y|mg/L|<7.5|N||A^S|F|||201910281020
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.
OBR|9|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|500.7020^PCT^Procalcitonin Level^^^33959-8||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|500.7050^PCT R^Procalcitonin Level^^33959-8^33959-8|1|0.20^^Y|ug/L|0.00-0.25|N||A^S|F|||201910281036
NTE|1||Procalcitonin Level:
NTE|2||Less than or equal to 0.25: Bacterial infection is very
NTE|3||                            unlikely.
NTE|4||Greater than 0.25 to 0.50: Bacterial infection is unlikely,
NTE|5||                           repeat within 24 h as indicated.
NTE|6||Greater than 0.50 to 0.90: Bacterial infection is possible.
NTE|7||Greater than 1.00: Bacterial infection is likely. Moderate
NTE|8||                   risk for sepsis.
NTE|9||Greater than 2.00: Bacterial infection is very likely. High
NTE|10||                   risk for sepsis.
OBR|10|34578^LAB|00026577^2810:C00003R^LAB^281019:C3^34578|522.2490^BHCG^Beta-HCG^^^21198-7||201910280954|201910280944|||||||201910280945||||||||||LAB|F||||
OBX|1|ST|522.2510^BHCG R^Beta-HCG^^21198-7^21198-7|1|< 5^^Y|IU/L|<10|N||A^S|F|||201910281020
NTE|1||Reference Intervals, (guideline only) FOR B-HCG (U/L):
NTE|2||
NTE|3||Male or non-pregnant female            Less than 10
NTE|4||Pregnant female:
NTE|5||Time after LMP:        Expected beta-HCG range(WHO 3rd IRP):
NTE|6||4th  week                               25 - 426
NTE|7||5th  week                               25 - 7340
NTE|8||6th  week                             1080 - 56500
NTE|9||10th week                            54100 - 288000
NTE|10||18th week                             8910 - 66000
NTE|11||31st week                             5310 - 27400
NTE|12||*************************NOTE*******************************
NTE|13||Occasional patients with heterophile antibodies may have
NTE|14||erroneous BHCG results. Serum BHCG should not be used for
NTE|15||routine pregnancy tests. Urine does not contain heterophile
NTE|16||antibodies and may be used where apparent discrepant results
NTE|17||are experienced.
NTE|18||Method:Beckman Access/DxI

MSH|^~\&|MIC|ARH|||201910241027||ORU^R01|4088337|D|2.3|||AL|NE
PID|1||AB00008279|AB8185|LABTESTCOLLIE^LUMED^||20050504|F||||||||||AB000559/19|9874974606
OBR|1|34459^MIC|00026488^19:M0000344R^MIC^19:M344^34459|400.1000^S^Sputum culture and gram stain^^^6460-0||201910240901|201910232230|||||||201910232300|Sputum^^^Expectorated|||||||||MB|F||||
NTE|1||Testing for LUMED
OBX|1|ST|100.0300^GSS^Gram stain^^664-3^664-3^P:GRAMS|1|||||||F|||201910241026
OBX|2|ST|100.0300^GSS^Gram stain^^664-3^664-3^R:4 P|1|4+ Polymorphonuclear cells||||||F|||201910241026
OBX|3|ST|100.0300^GSS^Gram stain^^664-3^664-3^R:4 GPC|1|4+ Gram positive cocci||||||F|||201910241026
OBX|4|ST|100.0300^GSS^Gram stain^^664-3^664-3^R:3 GNB|1|3+ Gram negative bacilli||||||F|||201910241026
OBX|5|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^P:MIXSC|2|||||||F|||201910241026
OBX|6|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^R:1 RF|2|1+ Respiratory flora||||||F|||201910241026
OBX|7|CE|400.2000^SC^Sputum culture^^6463-4^6460-0^O:SAUR|2.1|SAUR^Staphylococcus aureus||||||F|||201910241026
OBX|8|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^P:AMT|2.1|||||||F|||201910241026
OBX|9|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^R:4|2.1|4+||||||F|||201910241026
OBX|10|CE|400.2000^SC^Sputum culture^^6463-4^6460-0^O:SGC|2.2|SGC^Group C streptococcus||||||F|||201910241026
OBX|11|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^P:AMT|2.2|||||||F|||201910241026
OBX|12|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^R:4|2.2|4+||||||F|||201910241026
OBX|13|CE|400.2000^SC^Sputum culture^^6463-4^6460-0^O:KPNE|2.3|KPNE^Klebsiella pneumoniae||||||F|||201910241026
OBX|14|ST|400.2000^SC^Sputum culture^^6463-4^6460-0|2.3|||||||F|||201910241026
NTE|1||{Group C streptococcus}
NTE|2||Beta hemolytic group C Streptococci are universally
NTE|3||susceptible to the penicillins and cephalosporins, and
NTE|4||resistant to ciprofloxacin and
NTE|5||trimethoprim/sulfamethoxazole.  Alternate antibiotics are
NTE|6||clindamycin (80-90% susceptible) and erythromycin (70-80%
NTE|7||susceptible).
OBR|2||00026488^19:M0000344R^MIC^19:M344^34459|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||201910240901|201910232230|||||||201910232300|Sputum^^^Expectorated|||||||||MB|C|6463-4^2.1|||34459^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||201910241026
OBX|2|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||201910241026
OBX|3|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||S|||F|||201910241026
OBX|4|ST|200.600^OX^Cloxacillin^^197-4^197-4|||||S|||F|||201910241026
OBX|5|ST|400.200^E^Erythromycin^^233-7^233-7|||||S|||F|||201910241026
OBX|6|ST|400.300^CD^Clindamycin^^193-3^193-3|||||R|||F|||201910241026
OBX|7|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910241026
OBX|8|ST|800.000^VA^Vancomycin^^524-9^524-9|||||S|||F|||201910241026
OBR|3||00026488^19:M0000344R^MIC^19:M344^34459|903.3100^N213^Vitek N213 Sensitivity^^^29576-6||201910240901|201910232230|||||||201910232300|Sputum^^^Expectorated|||||||||MB|C|6463-4^2.3|||34459^MIC
OBX|1|ST|100.400^CFT^Cefotaxime^^108-1^108-1|||||S|||F|||201910241026
OBX|2|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||201910241026
OBX|3|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||I|||F|||201910241026
OBX|4|ST|101.100^CF^Cephalexin^^149-5^149-5|||||I|||F|||201910241026
OBX|5|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||201910241026
OBX|6|ST|300.000^AK^Amikacin^^12-5^12-5|||||S|||F|||201910241026
OBX|7|ST|300.100^TO^Tobramycin^^508-2^508-2|||||I|||F|||201910241026
OBX|8|ST|300.200^GM^Gentamicin^^267-5^267-5|||||R|||F|||201910241026
OBX|9|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910241026